CN Patent

CN1406245A — 去除人血清白蛋白多聚体的方法

Assigned to Chemo Sero Therapeutic Research Institute Kaketsuken · Expires 2003-03-26 · 23y expired

What this patent protects

将含有人血清白蛋白多聚体的人血清白蛋白溶液与用盐浓度为10～150mM、pH5～9.5的缓冲液平衡的阴离子交换体相接触，并且以此为特征的去除人血清白蛋白的方法。

USPTO Abstract

将含有人血清白蛋白多聚体的人血清白蛋白溶液与用盐浓度为10～150mM、pH5～9.5的缓冲液平衡的阴离子交换体相接触，并且以此为特征的去除人血清白蛋白的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1406245A
Jurisdiction
CN
Classification
—
Expires
2003-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.